Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.

Recombinant human immunodeficiency virus 1 (HIV-1) protease, purified from a bacterial expression system, processed a recombinant form of its natural substrate, Pr55gag, into protein fragments that possess molecular weights commensurate with those of the virion gag proteins. Molecular weights of the protease obtained under denaturing and nondenaturing conditions (11,000 and 22,000, respectively) and chemical crosslinking studies were consistent with a dimeric structure for the active enzyme. The protease appropriately cleaved the nonapeptide Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 between the tyrosine and proline residues. HIV-1 protease was sensitive to inactivators of the aspartic proteases. The aspartic protease inactivator 1,2-epoxy-3-(4-nitrophenoxy)propane produced irreversible, time-dependent inactivation of the protease. The pH-dependent kinetics of this inactivator were consistent with the requirement of an unprotonated carboxyl group in the active site of the enzyme, suggesting that HIV-1 protease is also an aspartic protease.

[1]  L J Davis,et al.  Active human immunodeficiency virus protease is required for viral infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Hansen,et al.  Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. , 1988, The EMBO journal.

[3]  S. L. Le Grice,et al.  Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli , 1988, Journal of virology.

[4]  E. Heimer,et al.  An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Varmus,et al.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.

[6]  C. Debouck,et al.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Yasunaga,et al.  Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor , 1987, Nature.

[8]  W R Taylor,et al.  Sequence specificity of retroviral proteases. , 1987, Nature.

[9]  C. Hutchison,et al.  Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. , 1987, Science.

[10]  I. Katoh,et al.  Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins , 1986, Journal of virology.

[11]  M. Shibuya,et al.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. , 1985, Virology.

[12]  I. Katoh,et al.  Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease , 1985, Journal of virology.

[13]  I. Katoh,et al.  Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Goff,et al.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins , 1985, Journal of virology.

[15]  L. Lasky,et al.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus , 1985, Nature.

[16]  K. Steimer,et al.  Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). , 1985, Science.

[17]  Olivier Danos,et al.  Nucleotide sequence of the AIDS virus, LAV , 1985, Cell.

[18]  S. Aaronson,et al.  Expression of the PDGF-related transforming protein of simian sarcoma virus in E. coli , 1984, Cell.

[19]  M. Rosenberg,et al.  Purification and properties of a transcriptional activator. The cII protein of phage lambda. , 1982, The Journal of biological chemistry.

[20]  R. Sauer,et al.  Amino acid sequence of p15 from avian myeloblastosis virus complex. , 1981, Biochemistry.

[21]  Y. Yoshinaka,et al.  Physicochemical characterization and specificity of the murine leukaemia virus Pr65gag proteolytic factor. , 1980, Journal of General Virology.

[22]  K. Moelling,et al.  Biochemical properties of p15-associated protease in an avian RNA tumor virus , 1978, Journal of virology.

[23]  M. James,et al.  Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin , 1977, Nature.

[24]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[25]  J. Tang,et al.  The carboxylate ion in the active center of pepsin. , 1972, The Journal of biological chemistry.

[26]  J. Tang,et al.  Specific and irreversible inactivation of pepsin by substrate-like epoxides. , 1971, The Journal of biological chemistry.

[27]  G R Stark,et al.  Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. J. Monty,et al.  Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases. , 1966, Biochimica et biophysica acta.

[29]  J. Kirkwood,et al.  Proteins, amino acids and peptides as ions and dipolar ions , 1943 .

[30]  T. Copeland,et al.  Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. , 1987, AIDS research and human retroviruses.

[31]  M. Rosenberg,et al.  Expression, identification, and characterization of recombinant gene products in Escherichia coli. , 1987, Methods in enzymology.

[32]  T. Platt,et al.  Maximizing gene expression from plasmid vectors containing the lambda PL promoter: strategies for overproducing transcription termination factor rho. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Cleland,et al.  The statistical analysis of enzyme kinetic data. , 1967, Advances in enzymology and related areas of molecular biology.